Tag: Hatch-Waxman Act

Brand manufacturers produce their own generic versions to retain market share after patents expire. These authorized generics are identical to the original drug but sold under a different label, often at a slightly lower price. Learn how they work, why they're controversial, and what it means for your prescription costs.

Patent litigation in the generic drug market is delaying affordable medicines for years. Learn how Hatch-Waxman, Orange Book listings, and pay-for-delay settlements are reshaping access to life-saving drugs.